Paradigm Biopharmaceuticals Ltd.ASX: PAR

Paradigm receives clarity on US regulatory pathway

Apr 6, 2020 at 3:09 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd. has released a press release.

View Attachment